FDA Guidance Documents·· 原文未提供具体时分
Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products: Draft Guidance for Industry and Other Interested Parties
Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products: Draft Guidance for Industry and Other Interested Parties
AI 导读
FDA 官方历史目录记录；Draft guidance；发布日期：2025-01-07。官方主题：Artificial Intelligence。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov